Skip to main content
FNNZF logo

FinCanna Capital Corp. (FNNZF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0029 $0.00 (0.00%)
MCap: $2.89M| Vol: 10.0K|

Market cap $2.89M is the value of all shares combined. Beta 1.03: the stock has moved about 3% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

FinCanna Capital Corp. (FNNZF) trades at $0.0029. FinCanna Capital Corp. is an investment firm providing financing solutions to companies in the licensed cannabis industry in the United States. Market cap: $2.89M, Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
FinCanna Capital Corp. is an investment firm providing financing solutions to companies in the licensed cannabis industry in the United States. The company focuses on royalty agreements with cannabis-related businesses.

Analyst Coverage for FNNZF: FNNZF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • ASPC · A SPAC III Acquisition Corp. · 43 /100
  • BKHA · Black Hawk Acquisition Corporation · 47 /100
  • AFJK · Aimei Health Technology Co., Ltd · 43 /100

See all scored stocks →

FinCanna Capital Corp. (FNNZF) Financial Services Profile

CEOVern Vipul
HeadquartersVancouver, CA
IPO Year2018

FinCanna Capital Corp., operating in the financial services sector, focuses on providing capital to licensed cannabis companies in the U.S. through royalty agreements. The company, incorporated in 2016, seeks to capitalize on the expanding cannabis market by offering alternative financing solutions.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for FNNZF?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

FinCanna Capital Corp. presents a unique investment opportunity within the rapidly expanding cannabis industry. The company's focus on royalty agreements provides a potentially stable revenue stream tied to the success of its cannabis partners. With a market capitalization of $2.89M and a beta of 1.03, FinCanna offers exposure to the cannabis sector with moderate volatility. Key value drivers include the growth of the U.S. cannabis market and the company's ability to secure favorable royalty agreements. Growth catalysts include the potential for further legalization of cannabis at the state and federal levels, which would significantly expand the market opportunity. However, potential risks include regulatory uncertainty, competition from other financing providers, and the inherent volatility of the cannabis industry. The company's success hinges on its ability to navigate these challenges and effectively deploy capital in promising cannabis ventures.

Based on FMP financials and quantitative analysis

FNNZF Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

FinCanna Capital Corp. operates as an investment company focused on the licensed cannabis industry in the United States.

  • The company's primary strategy involves establishing royalty agreements with cannabis companies.
  • FinCanna has royalty agreements with Green Compliance Inc. and Refined Resin.
  • The company was incorporated in 2016 and is headquartered in Vancouver, Canada.
  • FinCanna's market capitalization is $2.89M, indicating a micro-cap size.

Who Are FNNZF's Competitors?

FNNZF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
GLAE GlassBridge Enterprises, Inc. $28.00 0.00% —
ASPC A SPAC III Acquisition Corp. $10.20 -0.20% $23.8M 43 5-pillar
BKHA Black Hawk Acquisition Corporation $6.48 -24.74% $26.9M 47 5-pillar
AFJK Aimei Health Technology Co., Ltd $11.90 +0.76% $37.7M 43 5-pillar
AIB AIB Acquisition Corporation $0.63 -3.82% $48.5M 30 5-pillar
PGAC Pantages Capital Acquisition Corporation $10.87 -0.09% $55.8M 55 5-pillar
CHAR Charlton Aria Acquisition Corporation $10.99 +0.32% $57.6M 46 5-pillar
BPAC Bullpen Parlay Acquisition Company $10.31 +0.19% $76.1M 51 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FNNZF's Key Strengths?

Focus on the rapidly growing cannabis industry

  • Royalty-based financing model provides recurring revenue
  • Experienced management team with expertise in cannabis financing
  • Established relationships with cannabis companies

What Are FNNZF's Weaknesses?

Small market capitalization

  • Limited operating history
  • Dependence on the success of its portfolio companies
  • Exposure to regulatory uncertainty in the cannabis industry

What Are the Key Risks for FNNZF?

Regulatory uncertainty in the cannabis industry, which could negatively impact FinCanna's portfolio companies.

  • Increased competition from other investment firms and financial institutions entering the cannabis market.
  • Economic downturn that could reduce demand for cannabis products.
  • Volatility in the cannabis market, which could impact the value of FinCanna's investments.
  • Risks associated with investing in OTC stocks, including limited liquidity and regulatory oversight.

What Are FNNZF's Competitive Advantages?

  • Specialized expertise in cannabis financing
  • Established relationships with cannabis companies
  • Royalty-based financing model provides recurring revenue
  • Early mover advantage in a rapidly growing industry

What Does FNNZF Do?

FinCanna Capital Corp., established in 2016 and headquartered in Vancouver, Canada, operates as an investment company focused on the burgeoning licensed cannabis industry within the United States. Recognizing the capital constraints faced by many cannabis businesses, FinCanna provides tailored financing solutions designed to fuel growth and expansion. The company's primary strategy involves establishing royalty agreements with cannabis companies, allowing FinCanna to participate in the revenue streams generated by its partners. These agreements provide FinCanna with ongoing income linked directly to the success of the cannabis businesses they support. FinCanna's portfolio includes royalty agreements with companies such as Green Compliance Inc. and Refined Resin. These partnerships highlight FinCanna's commitment to supporting various segments within the cannabis value chain. By focusing on royalty-based financing, FinCanna aims to mitigate some of the risks associated with direct equity investments in a volatile and evolving industry. The company's approach allows it to diversify its exposure across multiple cannabis businesses, enhancing its overall stability. As the cannabis industry continues to mature and regulatory landscapes evolve, FinCanna Capital Corp. seeks to position itself as a key financial partner for licensed cannabis operators. The company's expertise in structuring royalty agreements and its deep understanding of the cannabis market differentiate it from traditional financial institutions. FinCanna's long-term success depends on its ability to identify and support promising cannabis businesses while effectively managing risk and adapting to changing market conditions.

What Products and Services Does FNNZF Offer?

  • FinCanna Capital Corp. invests in the licensed cannabis industry in the United States.
  • The company provides financing for cannabis companies.
  • FinCanna establishes royalty agreements with cannabis businesses.
  • The company supports various segments within the cannabis value chain.
  • FinCanna seeks to mitigate risk through royalty-based financing.
  • The company aims to be a key financial partner for licensed cannabis operators.

How Does FNNZF Make Money?

  • FinCanna Capital Corp. generates revenue through royalty agreements with cannabis companies.
  • The company receives a percentage of the revenue generated by its portfolio companies.
  • FinCanna's profitability is directly linked to the success of its cannabis partners.

What Industry Does FNNZF Operate In?

FinCanna Capital Corp. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and increasing acceptance. The market is characterized by a complex regulatory landscape and intense competition. FinCanna's focus on royalty agreements positions it as a financial partner for cannabis companies seeking alternative funding sources. The industry is projected to continue its expansion, driven by increasing legalization and changing consumer preferences. FinCanna faces competition from other investment firms and traditional financial institutions entering the cannabis market.

Who Are FNNZF's Key Customers?

  • Licensed cannabis cultivators
  • Cannabis processors and manufacturers
  • Cannabis retailers and dispensaries
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

FinCanna Capital Corp. operates in the Financial Services sector. It is headquartered in Vancouver, Canada.

F-Score 4/9

Financial Health

FinCanna Capital Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.

FNNZF Latest News

No recent news available for FNNZF.

FNNZF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FNNZF.

Price Targets

Wall Street price target analysis for FNNZF.

FNNZF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FNNZF; grades run from A+ (80-100) to F (below 30).

Leadership: Vern Vipul

CEO

Vern Vipul serves as the CEO of FinCanna Capital Corp. His background includes extensive experience in finance and investment management, with a focus on emerging industries. He has a proven track record of identifying and investing in high-growth companies. Vipul's expertise in structuring financial agreements and managing risk is crucial to FinCanna's success in the cannabis industry. His leadership is instrumental in guiding the company's strategic direction and fostering relationships with key stakeholders.

Track Record: Under Vern Vipul's leadership, FinCanna Capital Corp. has successfully established royalty agreements with several cannabis companies, expanding its portfolio and generating revenue. He has overseen the company's growth and navigated the complex regulatory landscape of the cannabis industry. Vipul's strategic decisions have positioned FinCanna as a key financial partner for cannabis operators, contributing to the company's growth and market presence.

FNNZF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that FinCanna Capital Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.

  • OTC Tier: OTC Other
Liquidity: As an OTC-listed stock, FNNZF likely experiences lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of the potential for price volatility and limited liquidity when trading FNNZF on the OTC market.
OTC Risk Factors:
  • Limited liquidity due to low trading volume
  • Lack of regulatory oversight compared to major exchanges
  • Potential for price manipulation and fraud
  • Limited financial information and disclosure
  • Higher risk of delisting or going out of business
Due Diligence Checklist:
  • Verify the company's registration and licensing status
  • Review the company's financial statements and disclosures
  • Assess the company's management team and track record
  • Evaluate the company's business model and competitive landscape
  • Understand the risks associated with investing in OTC stocks
  • Consult with a financial advisor before investing
  • Check for any regulatory actions or legal issues
Legitimacy Signals:
  • Company has been in operation for several years
  • Management team has relevant experience in the cannabis industry
  • Company has established partnerships with reputable cannabis companies
  • Company has a clear business model and revenue generation strategy
  • Company provides regular updates and disclosures to investors

FNNZF Financials Stock FAQ

What do analysts say about FNNZF stock?

As of 2026-03-17, formal analyst coverage of FNNZF is not widely available, likely due to its OTC listing and smaller market capitalization. Investors should conduct their own due diligence and consider the company's fundamentals, growth prospects, and risk factors.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial information available for FNNZF.
  • OTC stocks carry higher risks than exchange-listed stocks.
  • The cannabis industry is subject to regulatory uncertainty.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives